✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

GKB Ophthalmics Ltd.

GKB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹41 Cr.
P/E
0.00

GKB Ophthalmics Ltd.

  • GKB Ophthalmics
  • KMS Medisurgi
  • Amkay Products
FAQs on GKB Ophthalmics Ltd. Shareprice

GKB Ophthalmics has given better returns compared to its competitors.
GKB Ophthalmics has grown at ~-28.42% over the last 1yrs while peers have grown at a median rate of -32.53%

GKB Ophthalmics is not expensive.
Latest PE of GKB Ophthalmics is 0.0, while 3 year average PE is 11.3.
Also latest EV/EBITDA of GKB Ophthalmics is 0.0 while 3yr average is 67.02.

View FAQ's On Business
Growth Table
  • GKB Ophthalmics Ltd.
  • KMS Medisurgi
  • Amkay Products
Balance Sheet
  • GKB Ophthalmics Ltd.
  • KMS Medisurgi
  • Amkay Products
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • GKB Ophthalmics Ltd.
  • KMS Medisurgi
  • Amkay Products
Cash Flow
  • GKB Ophthalmics Ltd.
  • KMS Medisurgi
  • Amkay Products
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • GKB Ophthalmics Ltd.
  • KMS Medisurgi
  • Amkay Products
Quarterly Results
  • GKB Ophthalmics Ltd.
  • KMS Medisurgi
  • Amkay Products
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on GKB Ophthalmics Ltd. Financials

Balance sheet of GKB Ophthalmics is moderately strong, But short term working capital might become an issue for this company.

Yes, The net debt of GKB Ophthalmics is increasing.
Latest net debt of GKB Ophthalmics is -₹13.09 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹24.13 Crs.

No, profit is decreasing.
The profit of GKB Ophthalmics is -₹7.04 Crs for Mar 2025, -₹2.81 Crs for Mar 2024 and -₹0.17 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
GKB Ophthalmics latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech